Corporate · Global B2B
Antibody

Multiplex-Ready Antibody Portfolio

Verified primary antibodies, fluorophore conjugates, and multiplex-compatibility data for cytology and IF workflows.

Multiplex-Ready Antibody Portfolio visual

Regulatory note: Product availability, regulatory status, and intended use may vary by market. Please contact X-ZELL for current documentation.

Overview

Our antibody portfolio is verification-driven: each clone is tested on cell-line and cytology backgrounds and characterised for multiplex compatibility, conjugation, and intended workflow.

Key features

  • Verified clones
  • Multiplex compatibility data
  • Fluorophore-conjugated options
  • Cytology-relevant validation

Intended use

For research use and assay development.